DM
MGNX icon

Deerfield Management’s MacroGenics MGNX Stock Holding History

Deerfield Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-517,920
Closed -$9.71M – 111
2016
Q1 		$9.71M Hold
517,920
– – 0.41% 57
2015
Q4 		$16M Sell
517,920
-39,080
-7% -$1.19M 0.65% 55
2015
Q3 		$11.9M Buy
+557,000
New +$17.5M 0.46% 67

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Deerfield Management's MGNX Position: Q2 2016 in Review

Deerfield Management sold out of MacroGenics (MGNX) in Q2 2016, closing a stake of 517,920 shares — an estimated $9.71M sold.

Deerfield Management first reported a position in MGNX in Q3 2015 and held it in 3 quarters. The position peaked at $16M in Q4 2015. 125 funds tracked by Wall St. Rank hold MGNX as of Q2 2016.

  • Deerfield Management reported no remaining MacroGenics position as of Q2 2016 after selling out during the quarter.
  • Deerfield Management sold 517,920 MacroGenics shares in Q2 2016, an estimated $9.71M.
  • Deerfield Management first reported a position in MacroGenics in Q3 2015 and held it in 3 quarters.
  • Deerfield Management's MacroGenics position peaked at $16M in Q4 2015.
  • 125 funds tracked by Wall St. Rank held MacroGenics as of Q2 2016.

Based on Deerfield Management's 13F filing for Q2 2016, filed 15 Aug 2016.